iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea
· Delayed Price · Currency is KRW 4,195.00
-105.00 (-2.44%)
Apr 24, 2025, 3:30 PM KST
iNtRON Biotechnology Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -2,591 | -9,695 | 5,712 | 9,728 | 14,948 | Upgrade
|
| Depreciation & Amortization | 2,026 | 1,912 | 1,567 | 1,536 | 1,569 | Upgrade
|
| Loss (Gain) From Sale of Assets | -633.68 | -6.08 | 70.58 | 46.75 | -63.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | 96.64 | 1,986 | 1,188 | -443.93 | -1,087 | Upgrade
|
| Loss (Gain) on Equity Investments | 186.27 | -228.32 | -172.72 | - | - | Upgrade
|
| Stock-Based Compensation | 17.6 | 377.77 | 360.17 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -125.49 | -1,095 | 1,033 | 521.51 | 73.58 | Upgrade
|
| Other Operating Activities | -285.16 | 8,331 | -6,796 | 2,313 | 1,719 | Upgrade
|
| Change in Accounts Receivable | 1,211 | 2,937 | 5,163 | 1,643 | -9,239 | Upgrade
|
| Change in Inventory | -100.08 | -306.33 | 217.1 | 479.09 | -154.44 | Upgrade
|
| Change in Accounts Payable | 57.07 | -99.73 | -465.36 | 354.35 | -57.52 | Upgrade
|
| Change in Unearned Revenue | - | -1.17 | 4.89 | 48.49 | -35.97 | Upgrade
|
| Change in Other Net Operating Assets | 3.44 | -992.6 | -1,904 | 245.61 | -541.15 | Upgrade
|
| Operating Cash Flow | -138.47 | 3,118 | 5,977 | 16,473 | 7,131 | Upgrade
|
| Operating Cash Flow Growth | - | -47.84% | -63.72% | 131.00% | - | Upgrade
|
| Capital Expenditures | -1,122 | -7,791 | -2,229 | -3,046 | -4,852 | Upgrade
|
| Sale of Property, Plant & Equipment | 2,535 | 9 | - | 15 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -64.49 | -257.73 | -388.01 | -297.69 | 30.16 | Upgrade
|
| Investment in Securities | 1,058 | 61,273 | -43,676 | -38,082 | 8,003 | Upgrade
|
| Other Investing Activities | 87.01 | 357 | 80.66 | 130.44 | 91.73 | Upgrade
|
| Investing Cash Flow | 3,070 | 52,153 | -46,221 | -41,278 | 2,356 | Upgrade
|
| Long-Term Debt Issued | 861.44 | - | - | 40,000 | - | Upgrade
|
| Total Debt Issued | 861.44 | - | - | 40,000 | - | Upgrade
|
| Long-Term Debt Repaid | -174.62 | -40,168 | -196.82 | -250 | -2,010 | Upgrade
|
| Total Debt Repaid | -174.62 | -40,168 | -196.82 | -250 | -2,010 | Upgrade
|
| Net Debt Issued (Repaid) | 686.81 | -40,168 | -196.82 | 39,750 | -2,010 | Upgrade
|
| Repurchase of Common Stock | -7,186 | - | -8,994 | - | - | Upgrade
|
| Dividends Paid | -3,319 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -0.01 | -0.01 | -56.64 | Upgrade
|
| Financing Cash Flow | -9,818 | -40,168 | -9,191 | 39,750 | -2,066 | Upgrade
|
| Foreign Exchange Rate Adjustments | 258.96 | 72.75 | 76.59 | 298.74 | -907 | Upgrade
|
| Net Cash Flow | -6,628 | 15,175 | -49,359 | 15,243 | 6,514 | Upgrade
|
| Free Cash Flow | -1,260 | -4,673 | 3,748 | 13,427 | 2,279 | Upgrade
|
| Free Cash Flow Growth | - | - | -72.08% | 489.12% | - | Upgrade
|
| Free Cash Flow Margin | -19.64% | -48.75% | 26.76% | 45.81% | 5.02% | Upgrade
|
| Free Cash Flow Per Share | -38.30 | -140.80 | 110.49 | 398.07 | 64.59 | Upgrade
|
| Cash Interest Paid | - | 21.01 | 12.85 | 10.68 | 23.97 | Upgrade
|
| Cash Income Tax Paid | -405.72 | 293.4 | 1,184 | 229.22 | -134.45 | Upgrade
|
| Levered Free Cash Flow | -562.47 | -8,555 | 137.3 | 7,647 | -4,705 | Upgrade
|
| Unlevered Free Cash Flow | -547.84 | -6,731 | 2,328 | 8,669 | -3,965 | Upgrade
|
| Change in Net Working Capital | -1,874 | -1,190 | -4,046 | -4,178 | 10,548 | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.